Scientific Opinion on the substantiation of health claims related to
Lactobacillus plantarum 299v (DSM 9843) and “immune system” (ID 1081),
pursuant to Article 13(1) of Regulation (EC) No 1924/2006[sup]1[/sup]
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2, 3
European Food Safety Authority (EFSA), Parma, Italy
Słowa kluczowe:
Lactobacillus plantarum 299 (DSM 9843)
health claims
immune system
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claim is Lactobacillus plantarum 299v (DSM 9843). The identification/characterisation of the strain Lactobacillus plantarum 299v by both phenotypic (API 50CH) and genotypic methods is given (Johansson et al., 1993, 1995, 1998).
A reference number from the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen), DSM 9843, is provided. In the DSMZ, which is a non-public International Depositary Authority under the Budapest Treaty, cultures can be deposited in a restricted-access collection as Patent deposits.
The Panel considers that Lactobacillus plantarum 299v (DSM 9843), which is the subject of the health claim, is sufficiently characterised.
2. Znaczenie oświadczenia dla zdrowia człowieka
2.1. Układ odpornościowy (ID 1081)
The claimed effect is “immune system”. The Panel assumes that the target population is the general population.
The Panel considers that the claimed effect „immune system‟ is not sufficiently defined and no further details are given in the proposed wording. The references provided address several effects related to immune system (e.g. gut barrier function, systemic inflammatory response, antibody production) and it is not possible to establish which specific effect is the target for the claim.
The Panel considers that the claimed effect, “immune system”, has not been sufficiently defined.
The Panel concludes that a cause and effect relationship has not been established between the consumption of Lactobacillus plantarum 299v (DSM 9843) and “immune system”.
Wnioski
On the basis of the data presented, the Panel concludes that:
The food constituent, Lactobacillus plantarum 299v (DSM 9843), which is the subject of the health claim is sufficiently characterised.
The claimed effect is “immune system”. The target population is assumed to be the general population. “Immune system” has not been sufficiently defined.
A cause and effect relationship has not been established between the consumption of L plantarum 299v (DSM 9483) and “immune system”.
